コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 assist in the detection of low-flow states (low cardiac output).
2 ated with underfilling of the left heart and low cardiac output.
3 gement of patients with ADHF presenting with low cardiac output.
4 wer limb SCDs because they produce a falsely low cardiac output.
5 iliary circulatory support in the setting of low cardiac output.
6 severe arterial unsaturation, and usually a low cardiac output.
7 ospital mortality attributable to persisting low-cardiac output.
8 idence of perioperative infarction was 3.3%, low cardiac output 2.7%, stroke 2.2%, reoperation for bl
9 after tetralogy of Fallot repair results in low cardiac output and a prolonged stay in the intensive
12 of sepsis and was only found in models with low cardiac output and decreased renal blood flow (p < 0
13 recognized that these patients present with low cardiac output and high peripheral resistance and th
17 in principle by hypervolaemia, salt avidity, low cardiac output and normal left ventricular function.
19 both ventricles accompanied by hypotension, low cardiac output, and high filling pressures occurring
20 erative support techniques and postoperative low cardiac output are associated with cerebral hypoperf
22 ocusing on the importance of the syndrome of low cardiac output as a key feature of advanced heart fa
25 on of mitral regurgitation (MR) results in a low cardiac output (CO) state because of an acute increa
28 0.55), as well as persistent hypotension and low cardiac output (in 83 percent of the patients, vs. 1
29 rculation, which can be impaired either by a low cardiac output or arterial vasodilation, is an impor
31 ent, reflected the presence of an associated low cardiac output or low renal blood flow syndrome.
32 CI 1.1 to 1.7], p = 0.02), and postoperative low cardiac output (OR 3.0 [95% CI 1.7 to 5.2], p = 0.00
33 ed by elevated cardiac filling pressures and low cardiac output, or b) ongoing signs of hypoperfusion
34 acity in people with severe TR is related to low cardiac output reserve relative to metabolic needs,
35 ons, and (3) physiologic phenotypes, such as low cardiac output, right HF, cardiorenal syndromes, con
36 common use of inotropes and vasodilators for low cardiac output septic shock associated with elevated
37 a significant reduction in the incidence of low cardiac output state (odds ratio, 0.22; 95% confiden
38 a significant reduction in the incidence of low cardiac output state and the need for inotropic supp
40 ally challenging scenarios including AS with low cardiac output state or other structural heart disea
43 l in origin, including small aortic calibre, low cardiac output states, high vasopressor requirements
44 of infection (12.9% vs 29.7%; p = 0.002) and low cardiac output syndrome (6.5% vs 26.6%; p = 0.002).
50 ped relationship was observed for stroke and low cardiac output syndrome but not for renal replacemen
51 entification and aggressive treatment of the low cardiac output syndrome peculiar to these patients.
53 d 20.9% of the standard care group developed low cardiac output syndrome within 48 hours, needed extr
54 ailure were the most common causes of death (low cardiac output syndrome, 70 [36.5%]; multiorgan fail
55 econdary end points including a composite of low cardiac output syndrome, extracorporeal life support
56 rge as a composite of myocardial infarction, low cardiac output syndrome, infection, stroke, or in-ho
57 y bypass oxygenator may reduce postoperative low cardiac output syndrome, leading to improved recover
59 utcome (death within 30 days or in-hospital, low cardiac output syndrome, stroke, or Fontan takedown)
65 y of intervention, conversion to sternotomy, low cardiac output that required mechanical support, aor
66 tion died 7 weeks after surgery secondary to low cardiac output; the other 3 had resolution of effusi
68 y may potentially lead to an inappropriately low cardiac output, with a subsequent compromise of micr